Literature DB >> 12051903

Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering?

J M Squire1, M Chew, G Nneji, C Neal, J Barry, C Michel.   

Abstract

The luminal surface of endothelial cells is lined with the glycocalyx, a network structure of glycoproteins probably 50 to 100 nm thick. It has been suggested that a relatively regular fibre-matrix structure may be responsible for the ultrafiltration properties of microvascular walls, both when the endothelium is continuous and when it is fenestrated. Positive structural evidence demonstrating an underlying periodicity in the glycocalyx has been hard to obtain. Here we present structural analysis of glycocalyx samples prepared in a variety of ways for electron microscopy. Using computed autocorrelation functions and Fourier transforms of representative areas of the electron micrograph images, we show that there is an underlying three-dimensional fibrous meshwork within the glycocalyx with characteristic spacings of about 20 nm. Together with a fibre diameter consistent with our observations of about 10-12 nm, the 20-nm spacing provides just the size regime to account satisfactorily for the observed molecular filtering; the observations are consistent with the fibre matrix model. We also show that the fibrous elements may occur in clusters with a common intercluster spacing of about 100 nm and speculate that this may reveal organisation of the glycocalyx by a quasi-regular submembranous cytoskeletal scaffold. (c)2002 Elsevier Science (USA).

Mesh:

Year:  2001        PMID: 12051903     DOI: 10.1006/jsbi.2002.4441

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  77 in total

1.  LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans.

Authors:  C Charles Michel; M Nazeem Nanjee; Waldemar L Olszewski; Norman E Miller
Journal:  J Lipid Res       Date:  2014-11-14       Impact factor: 5.922

Review 2.  Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.

Authors:  Hemant Sarin
Journal:  Ther Deliv       Date:  2010-08

3.  Mechanotransduction and flow across the endothelial glycocalyx.

Authors:  Sheldon Weinbaum; Xiaobing Zhang; Yuefeng Han; Hans Vink; Stephen C Cowin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

4.  Oncotic pressures opposing filtration across non-fenestrated rat microvessels.

Authors:  R H Adamson; J F Lenz; X Zhang; G N Adamson; S Weinbaum; F E Curry
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

5.  Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro.

Authors:  Ke Bai; Wen Wang
Journal:  J R Soc Interface       Date:  2012-03-14       Impact factor: 4.118

Review 6.  Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge.

Authors:  Fitz-Roy E Curry; Roger H Adamson
Journal:  Cardiovasc Res       Date:  2010-04-23       Impact factor: 10.787

7.  Visualization of the glomerular endothelial glycocalyx by electron microscopy using cationic colloidal thorium dioxide.

Authors:  Jan Hegermann; Heinrich Lünsdorf; Matthias Ochs; Hermann Haller
Journal:  Histochem Cell Biol       Date:  2015-11-25       Impact factor: 4.304

Review 8.  Endothelial glycocalyx: permeability barrier and mechanosensor.

Authors:  F E Curry; R H Adamson
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

9.  Mapping bone interstitial fluid movement: displacement of ferritin tracer during histological processing.

Authors:  Cesare Ciani; Stephen B Doty; Susannah P Fritton
Journal:  Bone       Date:  2005-09       Impact factor: 4.398

10.  Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding.

Authors:  Ye Zeng; Roger H Adamson; Fitz-Roy E Curry; John M Tarbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.